USD10
ZBIO Shares
About Zenas BioPharmaZenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
USD10
ZBIO Shares
About Zenas BioPharmaZenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM UTC
MARKET CAP
$1.62B
OPEN PRICE
$25.36
LOW (1Y)
$13.50
HIGH (1Y)
$44.60
LOW (24H)
$24.51
HIGH (24H)
$25.96
VOLUME (24H)
$188.75K
61.37%
Price history
Time | Price | Change |
|---|---|---|
Today | $25.36 | |
1 Day | $25.49 | |
1 Week | $27.26 | |
1 Month | $32.32 | |
1 Year | $23.95 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.